Archive

8 posts

Showing results for: sham-controlled

5G Radio-Frequency-Electromagnetic-Field Effects on the Human Sleep Electroencephalogram: A Randomized Controlled Study in CACNA1C Genotyped Volunteers

Research RF Safe Research Library Jan 1, 2025

This randomized, double-blind, sham-controlled study tested whether CACNA1C rs7304986 genotype modifies sleep EEG responses to 5G RF-EMF exposure. The authors report a genotype-by-exposure interaction, with 3.6 GHz exposure in T/C carriers associated with a faster NREM sleep spindle center frequency versus sham. The…

Impact of expectancy on fatigue by exposure to the fifth generation of mobile communication signals

Research RF Safe Research Library Jan 1, 2025

This randomized sham-controlled study in 21 healthy participants tested whether routine-level 5G RF-EMF exposure affects fatigue and EEG power, while manipulating expectancy via correct, false, or no information about exposure order. The study reports no change in EEG power with real versus sham exposure. However,…

Effects of radiofrequency electromagnetic fields on cognitive function in elderly subjects (60+ years)-Results of an experimental randomized sham controlled double-blind cross-over study in women and in men.

Research RF Safe Research Library Jan 1, 2025

This double-blind randomized sham-controlled cross-over study tested short-term RF-EMF exposure effects on cognitive performance in 60 healthy adults aged 60–80 years. Participants completed attentional tasks during exposure to GSM 900 MHz, TETRA 385 MHz, or sham across nine sessions. Two of 16 outcomes showed…

EMAGINE-Study protocol of a randomized controlled trial for determining the efficacy of a frequency tuned electromagnetic field treatment in facilitating recovery within the subacute phase following ischemic stroke.

Research RF Safe Research Library Jan 1, 2023

This paper presents the protocol for the EMAGINE multicenter, double-blind, randomized, sham-controlled trial testing an extremely low-frequency, low-intensity, frequency-tuned electromagnetic field therapy (ENTF) after subacute ischemic stroke. Participants will start active or sham treatment 4–21 days post-stroke,…

Frequency-tuned electromagnetic field therapy improves post-stroke motor function: A pilot randomized controlled trial.

Research RF Safe Research Library Jan 1, 2022

This pilot randomized, sham-controlled, double-blind trial evaluated extremely low frequency, low-intensity ENTF electromagnetic field therapy in subacute ischemic stroke patients with impaired upper extremity function. The per-protocol results reported greater improvements in motor function and disability outcomes…

The Short-Term Effect of Occupational Levels of 50 Hz Electromagnetic Field on Human Heart Rate Variability.

Research RF Safe Research Library Jan 1, 2021

This double-blind randomized sham-controlled repeated-measures study examined short-term 50 Hz ELF-EMF exposure (28 μT) to the chest and its effects on HR and HRV in 34 healthy young men. HR deceleration occurred in both EMF and sham conditions, but several HRV indices (SDNN, RMSSD, LF, HF) increased only in the EMF…

Impact of low-level electromagnetic fields on the inducibility of atrial fibrillation in the electrophysiology laboratory.

Research RF Safe Research Library Jan 1, 2021

This randomized sham-controlled study tested low-level electromagnetic field stimulation (3.2 × 10 G at 0.89 Hz) applied around the head in patients undergoing ablation for paroxysmal atrial fibrillation. Eighteen patients completed the protocol, and LL-EMF was associated with shorter pacing-induced AF episodes after…

Pulsed radiofrequency in peripheral posttraumatic neuropathic pain: A double blind sham controlled randomized clinical trial.

Research RF Safe Research Library Jan 1, 2012

This double-blind, randomized, sham-controlled trial evaluated pulsed radiofrequency applied to injured peripheral nerves for peripheral posttraumatic neuropathic pain. Among 43 analyzed participants, PRF did not show statistically significant benefit over sham for pain reduction at 3 months, nor for neuropathic pain…

Page 1 / 1